Ligelizumab: A promising option on the horizon for the management of chronic spontaneous urticaria | Zendy

AI Assistant Blog Pricing

Open Access

Ligelizumab: A promising option on the horizon for the management of chronic spontaneous urticaria

Author(s) -

AnantD Patil,

Kiran Godse,

Gauri Godse

Publication year - 2021

Publication title -

indian journal of drugs in dermatology

Language(s) - English

Resource type - Journals

ISSN - 2455-3972

DOI - 10.4103/ijdd.ijdd_33_20

Subject(s) - omalizumab , medicine , immunoglobulin e , antihistamine , chronic urticaria , monoclonal antibody , antibody , monoclonal , immunology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Download on the

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.